Mind Medicine (MindMed) Investor Relations Material
Latest events
Q2 2025
Mind Medicine (MindMed)
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Mind Medicine (MindMed) Inc
Access all reports
Mind Medicine (MindMed) Inc is a biopharmaceutical company focused on the development of psychedelic-inspired medicines and therapies for mental health and addiction conditions. The company engages in clinical research and product development targeting various psychiatric and neurological disorders. MindMed operates within the healthcare and biotechnology sectors. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.
Key slides for Mind Medicine (MindMed) Inc
Q2 2025
Mind Medicine (MindMed) Inc
Q2 2025
Mind Medicine (MindMed) Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
MNMD
Country
🇺🇸 United States